Related Experiment Videos
The administration regimen of isepamicin in patients with chronic respiratory tract infection
1Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
Abstract:
A total of 34 patients with intractable chronic respiratory tract infections were treated with isepamicin and/or piperacillin in different dosage regimens. A comparison of the bacteriological effect using a cross over method showed a reduction in the count of Pseudomonas aeruginosa in sputum in the group receiving once-a-day isepamicin combined with piperacillin, compared with the twice-a-day combined administration. A comparison of the clinical and bacteriological efficacy between the different regimen groups revealed no noticeable difference. The clinical effect of this regimen is comparable to the conventional regimen, but has the advantages of a safer dosage and ease of administration.
Insights
Once-daily isepamicin with piperacillin reduced Pseudomonas aeruginosa in respiratory infections more effectively than twice-daily dosing. This regimen offers comparable clinical efficacy with improved safety and administration ease.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Microbiology
Background:
- Chronic respiratory tract infections pose significant treatment challenges.
- Pseudomonas aeruginosa is a common pathogen in these infections.
- Optimizing antibiotic regimens is crucial for patient outcomes.
Purpose of the Study:
- To compare the bacteriological and clinical efficacy of different dosage regimens of isepamicin and piperacillin.
- To evaluate the impact of once-daily versus twice-daily isepamicin combined with piperacillin.
- To assess the safety and administration advantages of novel regimens.
Main Methods:
- A crossover study design was employed with 34 patients.
- Patients received isepamicin and/or piperacillin in varying dosage regimens.
- Bacteriological counts of Pseudomonas aeruginosa in sputum were analyzed.
- Clinical efficacy and safety were compared across different treatment groups.
Main Results:
- Once-daily isepamicin combined with piperacillin demonstrated a greater reduction in Pseudomonas aeruginosa sputum counts compared to twice-daily administration.
- No significant differences in overall clinical or bacteriological efficacy were observed between the various regimen groups.
- The novel regimen showed comparable clinical effects to conventional treatments.
Conclusions:
- Once-daily isepamicin with piperacillin is a potentially more effective regimen for reducing Pseudomonas aeruginosa in chronic respiratory infections.
- This dosing strategy offers comparable clinical benefits to standard treatments.
- The once-daily regimen presents advantages in terms of improved safety and simpler administration.